The 20th Annual Cardiometabolic Health Congress (CMHC) is dedicated to various aspects of cardiovascular and metabolic diseases from a perspective of clinical intervention, risk assessment and prevention, focusing on the scientific basis and clinical tools essential to combat cardiometabolic risk, including Obesity, atherosclerosis, Hypertension, Insulin Resistance, Dyslipidemia, Type 2 Diabetes, thrombosis and Chronic Kidney Disease.
Physicians and other health professionals involved in endocrinology, internal medicine, cardiology, diabetes, primary care and metabolism.
